Chewy (CHWY) Earnings Analysis
Chewy (CHWY) next reports earnings on 2026-09-02, consensus EPS 0.36 USD. Last quarter (2026-06-10) it missed with EPS 0.23 USD vs 0.2424 USD est (-5.1%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 45.79.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CHWY next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | 0.36 USD |
| Revenue estimate | 3.32B |
CHWY earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-10 | 0.23 USD | 0.2424 USD | -5.1% | Miss |
| 2026-03-25 | 0.09 USD | 0.09232 USD | -2.5% | Miss |
| 2025-12-10 | 0.32 USD | 0.1248 USD | +156.4% | Beat |
| 2025-09-10 | 0.33 USD | 0.1427 USD | +131.3% | Beat |
| 2025-06-11 | 0.35 USD | 0.1668 USD | +109.8% | Beat |
| 2024-12-04 | 0.2 USD | 0.08 USD | +150% | Beat |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
CHWY valuation and analyst view
| Trailing P/E | 45.79 |
|---|---|
| Trailing EPS | 0.48166 USD |
| Price / book | 21.02 |
| Dividend yield | 0.00% |
| Market cap | 8.89B |
| Analyst consensus | Buy (31 buy / 7 hold / 0 sell) |
| Avg price target | 32.93 USD |
Related research pages
Frequently asked questions
When is Chewy (CHWY)'s next earnings date?
Chewy is next scheduled to report on 2026-09-02, with a consensus EPS estimate of 0.36 USD and revenue estimate of 3.32B.
Did CHWY beat earnings last quarter?
In its 2026-06-10 report, CHWY posted EPS of 0.23 USD versus a 0.2424 USD estimate — a miss of 5.1%.
What is CHWY's earnings track record?
Over the last 6 reported quarters with consensus data, CHWY beat estimates 4 times (67%).
What is CHWY's current P/E ratio and EPS?
CHWY trades at a trailing P/E of 45.79 on trailing EPS of 0.48166023166023164 USD.
What do analysts rate CHWY?
Analyst consensus is "Buy" across 38 ratings (0 strong buy, 31 buy, 7 hold, 0 sell, 0 strong sell). Average 12-month price target: 32.93 USD.